Transcranial magnetic stimulation is FDA-cleared and clinically established for treatment-resistant depression, yet a fully delivered course can still be denied over a missed prior authorization or an undocumented medication trial. TMS insurance coverage refers to the set of payer rules that determine whether, and under what conditions, a health plan will reimburse transcranial magnetic stimulation. Confirming coverage before the first session protects both the patient’s access to care and your Revenue Cycle Management Services workflow from a costly denial. This guide covers which payers typically pay for TMS therapy, what prior authorization requires, how session limits and re-treatment work, common denial causes, and how to appeal.

Why TMS Insurance Coverage Matters to Your Practice

Does insurance cover TMS therapy? Most major payers reimburse transcranial magnetic stimulation for major depressive disorder (MDD) when documented clinical criteria are met, but approval is never automatic. Coverage for TMS therapy depends on payer type—Medicare, state Medicaid, or a commercial plan—along with the plan’s specific medical policy, the treating psychiatrist’s network status, and the mental health parity requirements that apply to behavioral health treatments like TMS.

The financial stakes are significant: a denied claim after a full six-week course is often unrecoverable, since delivered sessions cannot be re-billed without documented proof of eligibility and authorization. A practice that outsources this work should confirm, in writing, which party is responsible when an authorization is missed, since different medical billing pricing models assign that responsibility differently.

Revenue cycle management (RCM)—the administrative and financial process covering intake through final payment—sits at the center of protecting this revenue. CMS’s Medicare Coverage Database billing and coding article for TMS, tied to Local Coverage Determination (LCD) L34641, outlines the documentation standards Medicare contractors apply before reimbursing a course of treatment.

TMS Insurance Coverage by Payer: Who Pays for TMS Therapy

Coverage for TMS therapy differs by payer. The summary below defines the term; the table outlines how major payer categories commonly treat TMS.

TMS insurance coverage refers to the payer-specific rules for reimbursing transcranial magnetic stimulation. Medicare Part B, most state Medicaid programs, and most commercial plans cover TMS for major depressive disorder when clinical necessity and prior authorization criteria are documented, though exact requirements must be confirmed with each plan.

Does Medicare cover TMS therapy? Medicare Part B does, under defined criteria. The table below lists commonly published coverage positions for payer categories your practice is likely to bill, and should never substitute for the plan’s current medical policy.

Workers’ compensation programs generally use their own coverage-determination process. UnitedHealthcare’s published commercial medical policy for TMS is one example of the payer-specific documents your team should keep on file.

Coverage verified: September 2026.

Prior Authorization Requirements for TMS Insurance Coverage

How do you get prior authorization for TMS? Prior authorization (PA) generally requires a confirmed diagnosis, documented failure of prior treatments, and clinical justification submitted before the first session, since payers rarely approve retroactive requests.

Most payers request the same core elements, roughly in order of importance: a confirmed diagnosis of major depressive disorder, single or recurrent episode, under the current Diagnostic and Statistical Manual (DSM-5); documented failure of, or intolerance to, prior antidepressant trials—most commercial plans require two to four adequate trials, sometimes structured as step therapy, while Medicare contractors may accept fewer under their Local Coverage Determination; a treatment plan from the ordering psychiatrist supporting treatment-resistant depression (TRD); and exclusion of contraindications such as a seizure disorder or an implanted metal device.

Payers increasingly require the ordering physician’s National Provider Identifier on the claim itself, not only on the authorization request; missing this detail has been documented by at least one Medicare contractor as a specific, preventable cause of first-level appeals. An ordering or treating psychiatrist who is not fully credentialed with a payer—a gap in payer enrollment and provider credentialing—can stall or invalidate TMS prior authorization entirely, which is why Credentialing Services should be confirmed before scheduling. A payer coverage policy defining TMS device history and clinical-necessity documentation standards illustrates how detailed these requirements can get.

TMS Session Limits, Treatment Courses, and Re-Treatment Rules

How many TMS sessions does insurance cover? A standard course of repetitive transcranial magnetic stimulation (rTMS) is commonly authorized for roughly 20 to 36 sessions delivered over six to nine weeks, though the exact number and duration are set by the payer’s medical policy rather than a universal standard.

The billing pattern follows a consistent shape even when the session count varies. An initial planning session, billed under CPT 90867, is followed by daily treatment sessions billed under CPT 90868, which requires redetermination of motor threshold, or CPT 90869, which does not. Most payers cap the initial authorized course and require clinical evidence of response—such as a documented symptom-scale improvement—before authorizing any extension. Accelerated, multiple-session-per-day protocols, including intermittent theta-burst stimulation (iTBS), are treated by several payers as investigational outside specific published criteria, so they require separate, plan-specific authorization rather than standard TMS session limits. Re-treatment after a relapse is typically considered only after documented improvement during the prior course, not as an automatic renewal.

Because TMS session limits affect how a course compares financially to other options, many practices track this alongside their mental health billing cost comparison. The Clinical TMS Society’s published lessons on U.S. insurance criteria and re-treatment thresholds is a useful field-level reference.

Common Reasons TMS Claims Are Denied and How to Prevent Them

Why was my TMS claim denied? Most TMS insurance denial cases trace back to a documentation or workflow gap, not an outright coverage exclusion, and each cause has a preventable control.

Missing or incomplete TMS prior authorization. Sessions are sometimes delivered before approval is confirmed in writing, a common cause of TMS insurance denial. Prevention: hold scheduling until the authorization number is on file.

Ordering psychiatrist not listed or not credentialed. Claims are submitted without the ordering physician’s required National Provider Identifier, or with a provider not yet in-network. Prevention: confirm credentialing status and timeline, including credentialing cost, before scheduling.

Insufficient antidepressant-trial documentation. The chart does not clearly show the antidepressant trials the payer’s medical necessity criteria require. Prevention: use a standardized documentation template completed before submission.

Session count exceeds the authorized number. Extensions beyond the initial course are billed without a new authorization on file. Prevention: track sessions against the authorized course directly in the practice management system.

Incorrect CPT code or motor-threshold documentation. CPT 90867 is billed for a session when 90868 or 90869 actually applies, or the motor-threshold note is incomplete. Prevention: have a coder review motor-threshold documentation before each claim goes out.

Many of these denials generate a specific claim adjustment reason code (CARC) worth logging by cause. The American Medical Association’s overview of the CPT code set, which it develops and maintains, is a useful reference for coding-related denials.

Appealing a Denied TMS Insurance Claim

How do you appeal a denied TMS claim? A denial is not always final. Documented clinical necessity, a valid authorization on file, or a straightforward coding correction can often support an appeal, though no outcome can ever be guaranteed.

The pattern behind a strong effort to appeal a TMS denial stays consistent across most payers. Start by reviewing the explanation of benefits (EOB) and the remittance advice to confirm the exact denial reason rather than assuming the cause. Next, gather the authorization confirmation, treatment notes, and medication-trial documentation that support the original claim. If the denial traces to a coding issue identified through the electronic remittance advice (ERA), correct it before resubmitting. Finally, file within the payer’s appeal window with a written clinical explanation tied to the specific denial reason.

Appeal windows, required forms, and reconsideration steps differ by payer, and Medicare and commercial plans handle reconsiderations differently from one another. CMS’s official resource explaining Claim Adjustment Reason Codes used on remittance advice is a helpful starting point, but your team should always confirm the current payer manual before filing, since a missed deadline can close the door on an otherwise strong appeal.

How to Verify and Track TMS Insurance Coverage in Your Practice

How do you verify TMS insurance benefits? Confirm the diagnosis and medication-trial criteria against the payer’s current medical policy, submit authorization before scheduling, and track session counts against the approved course throughout treatment.

A dependable verification workflow has four parts: a payer-specific coverage matrix built from each plan’s current medical policy; a benefits-verification step completed before intake, not after scheduling; a session-tracking queue tied to the authorized course so extensions are caught early; and scheduled re-verification of every payer’s policy after annual or plan-year changes. Verifying benefits up front also clarifies patient cost-sharing, including whether a Health Savings Account or Flexible Spending Account (HSA/FSA) applies toward any remaining balance.

Three key performance indicators (KPIs) are worth tracking against a baseline your team sets: authorization turnaround time, your TMS insurance denial rate, and the share of sessions completed within the authorized course. Treat any figure as illustrative, since the right baseline depends on your own payer mix.

Practices weighing outside support can review current service pricing against an in-house build-out. Washington State’s Department of Labor & Industries TMS coverage lookup tool is one example of a payer coverage-determination resource worth bookmarking.

How TMS Billings Supports TMS Insurance Coverage Compliance

TMS Billings applies a workflow built for this treatment: a payer coverage matrix, ongoing TMS prior authorization tracking, credentialing coordination for ordering and treating psychiatrists, session-count monitoring, and appeals supported by complete clinical documentation. Outsourced tracking can shorten the resubmission cycle compared with handling it in-house, though results vary by payer mix and no percentage is guaranteed.

This workflow can also run entirely in-house. TMS Billings supports practices that want added capacity, an independent second review, or ongoing support for their TMS program, working alongside your RCM and billing support team rather than replacing it.

At one multi-provider psychiatric practice, a patient’s TMS course was approved, but claims were denied after the ordering psychiatrist’s National Provider Identifier was left off during a system migration. Once the team added a pre-submission checklist confirming credentialing and authorization details, that denial cause stopped, and the outstanding claims were corrected and resubmitted.

Key Takeaways

• Most Medicare, Medicaid, and commercial plans reimburse TMS for major depressive disorder, though TMS insurance coverage hinges on documented clinical criteria.
• Secure TMS prior authorization before scheduling the first session, since retroactive requests are rarely approved by any payer.
• A standard course runs roughly 20 to 36 sessions, but the exact TMS session limits are set by each payer’s medical policy.
• Most denials trace to a missing authorization, absent credentialing, incomplete trial documentation, or a coding error—each has a preventable fix.
• A denied claim is not automatically final; a well-documented appeal filed within the payer’s window can still succeed.

Related reading: medical billing services cost in California and medical billing services cost in Texas; state- and payer-specific TMS coverage guides are planned as this library grows.

Final Thoughts

Your patients depend on TMS to work, and your practice depends on getting paid for delivering it. Treat TMS insurance coverage as a standing operational discipline, not a one-time check at intake: confirm authorization before every course, keep documentation airtight, and track sessions against the approved limit throughout treatment. Payer medical policies change periodically, sometimes without much notice, so confirm current requirements with each plan before scheduling a new course. If your team wants a second set of eyes on your TMS billing workflow, Book a Free Consultation with our coding and compliance team.